| |
|
Next Generation DNA Methylation Analysis
RiboMed provides researchers studying DNA methylation with optimized assays that enable sensitive and specific DNA methylation profiling. Our MethylMagnet® technology enables bisulfite-free isolation of methylated and unmethylated DNA for downstream profiling. Our customers work in academic and diagnostic labs that demand better performing alternatives to bisulfite-based DNA methylation analysis.
RiboMed DNA Methylation Research Technologies
Our MethylMagnet® technology can be accessed in a flexible product and service offering including to suit most research scenarios: |
|
RiboMed News
November 2010
John Chiplin joins RiboMed’s Board of Directors.
October 2010
RiboMed Appoints Dr. David Alberts as Chariman of Newly Formed Clinical Advisory Board.
September 2010
CSO David McCarthy Speaks at Epigenetics Europe in Dublin Ireland.
|
|